Quercetin and cancer chemoprevention

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Cossarizza, Andrea ^a   Gibellini, Lara ^a   Pinti, Marcello ^a   Nasi, Milena ^a   Montagna, Jonas P ^a   De Biasi, Sara ^a   Roat, Erika ^a   Bertoncelli, Linda ^a   Cooper, Edwin L ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATECHIN; CURCUMIN; FLAVONOID; PROTEIN P53; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLADDER TUMOR; BONE METASTASIS; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROLIFERATION; COLON CARCINOGENESIS; DIET; DIETARY INTAKE; DNA METHYLATION; DRUG SAFETY; HUMAN; ILEUM CANCER; INTESTINE TUMOR; LIVER CELL CARCINOMA; LIVER METASTASIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; TEA; UNSPECIFIED SIDE EFFECT;

EID: 79959266277     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/neq053     Document Type: Review

References (166)

1. Kennedy D. A., Hart J., Seely D., Cost effectiveness of natural health products: a systematic review of randomized clinical trials Evidence-Based Complementary and Alternative Medicine 2009 6 3 297 304
2. Danaei G., Vander Hoorn S., Lopez A. D., Murray C. J. L., Ezzati M., Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors Lancet 2005 366 9499 1784 1793 (Pubitemid 41642642)
3. Knekt P., Kumpulainen J., Jrvinen R., Rissanen H., Helivaara M., Reunanen A., Hakulinen T., Aromaa A., Flavonoid intake and risk of chronic diseases American Journal of Clinical Nutrition 2002 76 3 560 568 (Pubitemid 34920833)
4. Manson M. M., Cancer preventionthe potential for diet to modulate molecular signalling Trends in Molecular Medicine 2003 9 1 11 18 (Pubitemid 36139250)
5. Van Duijnhoven F. J. B., Bueno-De-Mesquita H. B., Ferrari P., Jenab M., Boshuizen H. C., Ros M. M., Casagrande C., Tjnneland A., Olsen A., Overvad K., Thorlacius-Ussing O., Clavel-Chapelon F., Boutron-Ruault M.-C., Morois S., Kaaks R., Linseisen J., Boeing H., Nthlings U., Trichopoulou A., Trichopoulos D., Misirli G., Palli D., Sieri S., Panico S., Tumino R., Vineis P., Peeters P. H. M., Van Gils C. H., Ock M. C., Lund E., Engeset D., Skeie G., Surez L. R., Gonzlez C. A., Snchez M.-J., Dorronsoro M., Navarro C., Barricarte A., Berglund G., Manjer J., Hallmans G., Palmqvist R., Bingham S. A., Khaw K.-T., Key T. J., Allen N. E., Boffetta P., Slimani N., Rinaldi S., Gallo V., Norat T., Riboli E., Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition American Journal of Clinical Nutrition 2009 89 5 1441 1452
6. Anderson L. A., Watson R. G., Murphy S. J., Johnston B. T., Comber H., Mc Guigan J., Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study World Journal of Gastroenterology 2007 13 1585 1594 (Pubitemid 46672669)
7. Terry P., Lagergren J., Hansen H., Wolk A., Nyrn O., Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers European Journal of Cancer Prevention 2001 10 4 365 369 (Pubitemid 32735353)
8. Alberg A. J., Brock M. V., Samet J. M., Epidemiology of lung cancer: looking to the future Journal of Clinical Oncology 2005 23 14 3175 3185 (Pubitemid 46217457)
9. Feskanich D., Ziegler R. G., Michaud D. S., Giovannucci E. L., Speizer F. E., Willett W. C., Colditz G. A., Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women Journal of the National Cancer Institute 2000 92 22 1812 1823
10. Kirsh V. A., Peters U., Mayne S. T., Subar A. F., Chatterjee N., Johnson C. C., Hayes R. B., Prospective study of fruit and vegetable intake and risk of prostate cancer Journal of the National Cancer Institute 2007 99 15 1200 1209 (Pubitemid 47233070)
11. Wolk A., Gridley G., Niwa S., Lindblad P., McCredie M., Mellemgaard A., Mandel J. S., Wahrendorf J., McLaughlin J. K., Adami H.-O., International renal cell cancer study. VII. Role of diet International Journal of Cancer 1996 65 1 67 73 (Pubitemid 26027539)
12. Bravi F., Bosetti C., Scotti L., Talamini R., Montella M., Ramazzotti V., Negri E., Franceschi S., La Vecchia C., Food groups and renal cell carcinoma: a case-control study from Italy International Journal of Cancer 2007 120 3 681 685 (Pubitemid 44969041)
13. Yuan J.-M., Gago-Dominguez M., Castelao E., Hankin J. H., Ross R. K., Yu M. C., Cruciferous vegetables in relation to renal cell carcinoma International Journal of Cancer 1998 77 2 211 216 (Pubitemid 28287971)
14. Buchner F. L., Bueno-de-Mesquita H. B., Ros M. M., Kampman E., Egevad L., Overvad K., Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition International Journal of Cancer 2009 125 2643 2651
15. Surh Y.-J., Cancer chemoprevention with dietary phytochemicals Nature Reviews Cancer 2003 3 10 768 780 (Pubitemid 37328815)
16. Ki W. L., Hyong J. L., The roles of polyphenols in cancer chemoprevention BioFactors 2006 26 2 105 121 (Pubitemid 43979363)
17. Ravindranath M. H., Ramasamy V., Moon S., Ruiz C., Muthugounder S., Differential growth suppression of human melanoma cells by tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG) Evidence-Based Complementary and Alternative Medicine 2009 6 523 530
18. Ravindranath M. H., Saravanan T. S., Monteclaro C. C., Presser N., Ye X., SelVan S. R., Brosman S., Epicatechins purified from green tea (Camellia sinensis) differentially suppress growth of gender-dependent human cancer cell lines Evidence-Based Complementary and Alternative Medicine 2006 3 2 237 247
19. Salvioli S., Sikora E., Cooper E. L., Franceschi C., Curcumin in cell death processes: a challenge for CAM of age-related pathologies Evidence-Based Complementary and Alternative Medicine 2007 4 2 181 190
20. Bufalo M. C., Candeias J. M., Sforcin J. M., In vitro cytotoxic effect of Brazilian Green Propolis on human laryngeal epidermoid carcinoma (HEp-2) cells Evidence-Based Complementary and Alternative Medicine 2009 6 483 487
21. Chatelain K., Phippen S., McCabe J., Teeters C. A., O'Malley S., Kingsley K., Cranberry and grape seed extracts inhibit the proliferative phenotype of oral squamous cell carcinomas Evidence-Based Complementary and Alternative Medicine 2008
22. Mandal S., Hazra B., Sarkar R., Biswas S., Mandal N., Assessment of the antioxidant and reactive oxygen species scavenging activity of methanolic extract of Caesalpinia crista leaf Evidence-Based Complementary and Alternative Medicine 2009
23. Matsunaga N., Chikaraishi Y., Shimazawa M., Yokota S., Hara H., Vaccinium myrtillus (Bilberry) extracts reduce angiogenesis in vitro and in vivo Evidence-Based Complementary and Alternative Medicine 2007
24. Ou T. T., Wang C. J., Hung G. U., Wu C. H., Lee H. J., Aqueous extract of Shi-Liu-Wei-Liu-Qi-Yin induces G2/M phase arrest and apoptosis in human bladder carcinoma cells via fas and mitochondrial pathway Evidence-Based Complementary and Alternative Medicine 2009
25. Szliszka E., Czuba Z. P., Bronikowska J., Mertas A., Paradysz A., Krol W., Ethanolic extract of Propolis augments TRAIL-induced apoptotic death in prostate cancer cells Evidence-Based Complementary and Alternative Medicine 2009
26. Chien S.-Y., Wu Y.-C., Chung J.-G., Yang J.-S., Lu H.-F., Tsou M.-F., Wood W., Kuo S.-J., Chen D.-R., Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells Human and Experimental Toxicology 2009 28 8 493 503
27. Naithani R., Huma L. C., Moriarty R. M., McCormick D. L., Mehta R. G., Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials Current Medicinal Chemistry 2008 15 11 1044 1071 (Pubitemid 352005717)
28. Notarbartolo M., Poma P., Perri D., Dusonchet L., Cervello M., D'Alessandro N., Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression Cancer Letters 2005 224 53 65 (Pubitemid 40720367)
29. Vijayababu M. R., Arunkumar A., Kanagaraj P., Venkataraman P., Krishnamoorthy G., Arunakaran J., Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3) Molecular and Cellular Biochemistry 2006 287 1-2 109 116 (Pubitemid 44057398)
30. Gescher A., Pastorino U., Plummer S. M., Manson M. M., Suppression of tumour development by substances derived from the dietmechanisms and clinical implications British Journal of Clinical Pharmacology 1998 45 1 1 12 (Pubitemid 28062847)
31. Milner J. A., McDonald S. S., Anderson D. E., Greenwald P., Molecular targets for nutrients involved with cancer prevention Nutrition and Cancer 2001 41 1-2 1 16 (Pubitemid 34666215)
32. Hussain S. P., Hofseth L. J., Harris C. C., Radical causes of cancer Nature Reviews Cancer 2003 3 4 276 285 (Pubitemid 37328863)
33. Devasena T., Menon V. P., Rajasekharan K. N., Prevention of 1,2-dimethylhydrazine-induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione during colon carcinogenesis Pharmacological Reports 2006 58 2 229 235
34. Liebler D. C., Burr J. A., Effects of UV light and tumor promoters on endogenous vitamin E status in mouse skin Carcinogenesis 2000 21 2 221 225 (Pubitemid 30098706)
35. Slaga T. J., Klein-Szanto A. J. P., Triplett L. L., Yotti L. P., Trosko J. E., Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound Science 1981 213 4511 1023 1025
36. Huang R.-P., Peng A., Hossain M. Z., Fan Y., Jagdale A., Boynton A. L., Tumor promotion by hydrogen peroxide in rat liver epithelial cells Carcinogenesis 1999 20 3 485 492 (Pubitemid 29112639)
37. Zhao Y., Chaiswing L., Oberley T. D., Batinic-Haberle I., St. Clair W., Epstein C. J., St. Clair D., A mechanism-based antioxidant approach for the reduction of skin carcinogenesis Cancer Research 2005 65 4 1401 1405 (Pubitemid 40270168)
38. Zhang Y., Ikeno Y., Qi W., Chaudhuri A., Li Y., Bokov A., Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity The Journals of Gerontology. Series A 2009 64 1212 1220
39. Fukuyama M., Rokutan K., Sano T., Miyake H., Shimada M., Tashiro S., Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon Cancer Letters 2005 221 1 97 104 (Pubitemid 40387913)
40. Lim S. D., Sun C., Lambeth J. D., Marshall F., Amin M., Chung L., Petros J. A., Arnold R. S., Increased Nox1 and hydrogen peroxide in prostate cancer Prostate 2005 62 2 200 207 (Pubitemid 40096784)
41. Arnold R. S., He J., Remo A., Ritsick D., Qiqin Y.-G., Lambeth J. D., Datta M. W., Young A. N., Petros J. A., Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1 American Journal of Pathology 2007 171 6 2021 2032
42. Cullen J. J., Weydert C., Hinkhouse M. M., Ritchie J., Domann F. E., Spitz D., Oberley L. W., The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma Cancer Research 2003 63 6 1297 1303 (Pubitemid 36348708)
43. Hehner S. P., Breitkreutz R., Shubinsky G., Unsoeld H., Schulze-Osthoff K., Schmitz M. L., Droge W., Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool Journal of Immunology 2000 165 8 4319 4328
44. Poli G., Leonarduzzi G., Biasi F., Chiarpotto E., Oxidative stress and cell signalling Current Medicinal Chemistry 2004 11 9 1163 1182 (Pubitemid 38585060)
45. Valko M., Izakovic M., Mazur M., Rhodes C. J., Telser J., Role of oxygen radicals in DNA damage and cancer incidence Molecular and Cellular Biochemistry 2004 266 1-2 37 56 (Pubitemid 39562306)
46. Jackson A. L., Loeb L. A., The contribution of endogenous sources of DNA damage to the multiple mutations in cancer Mutation Research 2001 477 1-2 7 21 (Pubitemid 32480184)
47. Klungland A., Rosewell I., Hollenbach S., Larsen E., Daly G., Epe B., Seeberg E., Lindahl T., Barnes D. E., Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage Proceedings of the National Academy of Sciences of the United States of America 1999 96 23 13300 13305
48. Beckman K. B., Ames B. N., Oxidative decay of DNA Journal of Biological Chemistry 1997 272 32 19633 19636 (Pubitemid 27340047)
49. Liu S. L., Lin X., Shi D. Y., Cheng J., Wu C. Q., Zhang Y. D., Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways Archives of Biochemistry and Biophysics 2002 406 173 182 (Pubitemid 35216343)
50. Veeramani S., Yuan T.-C., Lin F.-F., Lin M.-F., Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells Oncogene 2008 27 37 5057 5068
51. Thornber K., Colomba A., Ceccato L., Delsol G., Payrastre B., Gaits-Iacovoni F., Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas Oncogene 2009 28 29 2690 2696
52. Ramos S., Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention Journal of Nutritional Biochemistry 2007 18 7 427 442 (Pubitemid 46874924)
53. Bravo L., Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance Nutrition Reviews 1998 56 11 317 333 (Pubitemid 28532456)
54. Rice-Evans C., Flavonoid antioxidants Current Medicinal Chemistry 2001 8 797 807 (Pubitemid 32427907)
55. Scalbert A., Williamson G., Dietary intake and bioavailability of polyphenols Journal of Nutrition 2000 130 2073S 2085S (Pubitemid 30619386)
56. Perez-Vizcaino F., Duarte J., Jimenez R., Santos-Buelga C., Osuna A., Antihypertensive effects of the flavonoid quercetin Pharmacological Reports 2009 61 1 67 75
57. Russo G. L., Ins and outs of dietary phytochemicals in cancer chemoprevention Biochemical Pharmacology 2007 74 4 533 544 (Pubitemid 47042006)
58. Manach C., Williamson G., Morand C., Scalbert A., Remesy C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies American Journal of Clinical Nutrition 2005 81 230S 242S
59. Chen C., Ah-Ng T. K., Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects Trends in Pharmacological Sciences 2005 26 6 318 326 (Pubitemid 40733525)
60. Williams R. J., Spencer J. P. E., Rice-Evans C., Flavonoids: antioxidants or signalling molecules? Free Radical Biology and Medicine 2004 36 7 838 849 (Pubitemid 38352901)
61. Qiao Y., Cao J., Xie L., Shi X., Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells Archives of Pharmacal Research 2009 32 9 1309 1315
62. Wang X., Hao M. W., Dong K., Lin F., Ren J. H., Zhang H. Z., Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression Archives of Pharmacal Research 2009 32 1263 1269
63. Lee Y. K., Hwang J. T., Kwon D. Y., Surh Y. J., Park O. J., Induction of apoptosis by quercetin is mediated through AMPKalpha1/ASK1/p38 pathway Cancer Letters 2010 292 228 236
64. Philips B. J., Coyle C. H., Morrisroe S. N., Chancellor M. B., Yoshimura N., Induction of apoptosis in human bladder cancer cells by green tea catechins Biomedical Research 2009 30 4 207 215
65. Nihal M., Ahsan H., Siddiqui I. A., Mukhtar H., Ahmad N., Wood G. S., (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma Cell Cycle 2009 8 13 2057 2063
66. Wu P. P., Kuo S. C., Huang W. W., Yang J. S., Lai K. C., Chen H. J., (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway Anticancer Research 2009 29 1435 1442
67. Yamauchi R., Sasaki K., Yoshida K., Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549 Toxicology in Vitro 2009 23 5 834 839
68. Valcic S., Burr J. A., Timmermann B. N., Liebler D. C., Antioxidant chemistry of green tea catechins. New oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin from their reactions with peroxyl radicals Chemical Research in Toxicology 2000 13 9 801 810
69. Miller N. J., Rice-Evans C. A., Antioxidant activity of resveratrol in red wine Clinical Chemistry 1995 41 12 1789
70. Es-Safi N.-E., Ghidouche S., Ducrot P. H., Flavonoids: hemisynthesis, reactivity, characterization and free radical scavenging activity Molecules 2007 12 9 2228 2258
71. Laughton M. J., Evans P. J., Moroney M. A., Hoult J. R., Halliwell B., Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability Biochemical Pharmacology 1991 42 1673 1681
72. Raso G. M., Meli R., Di Carlo G., Pacilio M., Di Carlo R., Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1 Life Sciences 2001 68 8 921 931 (Pubitemid 32168067)
73. Schewe T., Khn H., Sies H., Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase Journal of Nutrition 2002 132 7 1825 1829 (Pubitemid 34742863)
74. Sheu S.-Y., Lai C.-H., Chiang H.-C., Inhibition of xanthine oxidase by purpurogallin and silymarin group Anticancer Research 1998 18 1 263 267 (Pubitemid 28174717)
75. Siess M. H., Mas J. P., Canivenc-Lavier M. C., Suschetet M., Time course of induction of rat hepatic drug-metabolizing enzyme activities following dietary administration of flavonoids Journal of Toxicology and Environmental Health 1996 49 481 496
76. Lu J., Papp L. V., Fang J., Rodriguez-Nieto S., Zhivotovsky B., Holmgren A., Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity Cancer Research 2006 66 8 4410 4418
77. Borra M. T., Smith B. C., Denu J. M., Mechanism of human SIRT1 activation by resveratrol Journal of Biological Chemistry 2005 280 17 17187 17195 (Pubitemid 41389185)
78. Haigis M. C., Sinclair D. A., Mammalian sirtuins: biological insights and disease relevance Annual Review of Pathology 5 253 295
79. Bourguignon L. Y., Xia W., Wong G., Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells The Journal of Biological Chemistry 2009 284 2657 2671
80. Tan S., Wang C., Lu C., Zhao B., Cui Y., Shi X., Ma X., Quercetin is able to demethylate the p16INK4a gene promoter Chemotherapy 2008 55 1 6 10
81. Kim Y.-H., Lee D.-H., Jeong J.-H., Guo Z. S., Lee Y. J., Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway Biochemical Pharmacology 2008 75 10 1946 1958
82. Bosetti C., Rossi M., McLaughlin J. K., Negri E., Talamini R., Lagiou P., Montella M., Ramazzotti V., Franceschi S., LaVecchia C., Flavonoids and the risk of renal cell carcinoma Cancer Epidemiology Biomarkers and Prevention 2007 16 1 98 101 (Pubitemid 46174270)
83. Bosetti C., Spertini L., Parpinel M., Gnagnarella P., Lagiou P., Negri E., Franceschi S., Montella M., Peterson J., Dwyer J., Giacosa A., La Vecchia C., Flavonoids and breast cancer risk in Italy Cancer Epidemiology Biomarkers and Prevention 2005 14 4 805 808 (Pubitemid 40478539)
84. Hirvonen T., Pietinen P., Virtanen M., Ovaskainen M.-L., Hkkinen S., Albanes D., Virtamo J., Intake of flavonols and flavones and risk of coronary heart disease in male smokers Epidemiology 2001 12 1 62 67 (Pubitemid 32006463)
85. De Stefani E., Boffetta P., Deneo-Pellegrini H., Mendilaharsu M., Carzoglio J. C., Ronco A., Olivera L., Dietary antioxidants and lung cancer risk: a case-control study in Uruguay Nutrition and Cancer 1999 34 1 100 110 (Pubitemid 29382922)
86. Hertog M. G., Hollman P. C., Katan M. B., Kromhout D., Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands Nutrition and Cancer 1993 20 21 29 (Pubitemid 23225364)
87. Bobe G., Weinstein S. J., Albanes D., Hirvonen T., Ashby J., Taylor P. R., Virtamo J., Stolzenberg-Solomon R. Z., Flavonoid intake and risk of pancreatic cancer in male smokers (Finland) Cancer Epidemiology Biomarkers and Prevention 2008 17 3 553 562 (Pubitemid 351469204)
88. Nthlings U., Murphy S. P., Wilkens L. R., Henderson B. E., Kolonel L. N., Flavonols and pancreatic cancer risk: the multiethnic cohort study American Journal of Epidemiology 2007 166 8 924 931 (Pubitemid 47511689)
89. Gates M. A., Tworoger S. S., Hecht J. L., De Vivo I., Rosner B., Hankinson S. E., A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer International Journal of Cancer 2007 121 10 2225 2232 (Pubitemid 47585602)
90. Lin J., Zhang S. M., Wu K., Willett W. C., Fuchs C. S., Giovannucci E., Flavonoid intake and colorectal cancer risk in men and women American Journal of Epidemiology 2006 164 7 644 651 (Pubitemid 44453493)
91. Theodoratou E., Kyle J., Cetnarskyj R., Farrington S. M., Tenesa A., Barnetson R., Porteous M., Dunlop M., Campbell H., Dietary flavonoids and the risk of colorectal cancer Cancer Epidemiology Biomarkers and Prevention 2007 16 4 684 693 (Pubitemid 46650569)
92. Cui Y., Morgenstern H., Greenland S., Tashkin D. P., Mao J. T., Cai L., Cozen W., Mack T. M., Lu Q.-Y., Zhang Z.-F., Dietary flavonoid intake and lung cancera population-based case-control study Cancer 2008 112 10 2241 2248 (Pubitemid 351628635)
93. Amin A. R., Kucuk O., Khuri F. R., Shin D. M., Perspectives for cancer prevention with natural compounds Journal of Clinical Oncology 2009 27 16 2712 2725
94. Beecher G. R., Warden B. A., Merken H., Analysis of tea polyphenols Proceedings of the Society for Experimental Biology and Medicine 1999 220 4 267 270 (Pubitemid 29153138)
95. Formica J. V., Review of the biology of quercetin and related bioflavonoids Food and Chemical Toxicology 1995 33 12 1061 1080 (Pubitemid 26009773)
96. Hollman P. C. H., Katan M. B., Dietary flavonoids: intake, health effects and bioavailability Food and Chemical Toxicology 1999 37 9-10 937 942 (Pubitemid 29481795)
97. Noroozi M., Burns J., Crozier A., Kelly I. E., Lean M. E. J., Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion European Journal of Clinical Nutrition 2000 54 2 143 149 (Pubitemid 30162885)
98. O'Leary K. A., Day A. J., Needs P. W., Mellon F. A., O'Brien N. M., Williamson G., Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism Biochemical Pharmacology 2003 65 479 491 (Pubitemid 36084565)
99. Day A. J., Mellon F., Barron D., Sarrazin G., Morgan M. R. A., Williamson G., Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin Free Radical Research 2001 35 6 941 952 (Pubitemid 34065683)
100. O'Leary K. A., Day A. J., Needs P. W., Sly W. S., O'Brien N. M., Williamson G., Flavonoid glucuronides are substrates for human liver beta-glucuronidase FEBS Letters 2001 503 103 106 (Pubitemid 32769964)
101. Lugli E., Ferraresi R., Roat E., Troiano L., Pinti M., Nasi M., Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells Leukemia Research 2009 33 140 150
102. Heijnen C. G. M., Haenen G. R. M. M., Van Acker F. A. A., Van Der Vijgh W. J. F., Bast A., Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups Toxicology in Vitro 2001 15 1 3 6 (Pubitemid 32226368)
103. Metodiewa D., Jaiswal A. K., Cenas N., Dickancaite E., Segura-Aguilar J., Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product Free Radical Biology and Medicine 1999 26 107 116 (Pubitemid 29001498)
104. Yoshino M., Haneda M., Naruse M., Murakami K., Prooxidant activity of flavonoids: copper-dependent strand breaks and the formation of 8-hydroxy- 2′ -deoxyguanosine in DNA Molecular Genetics and Metabolism 1999 68 468 472 (Pubitemid 30043553)
105. Boots A. W., Kubben N., Haenen G. R., Bast A., Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation Biochemical and Biophysical Research Communications 2003 308 560 565 (Pubitemid 36945529)
106. Spencer J. P. E., Kuhnle G. G. C., Williams R. J., Rice-Evans C., Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites Biochemical Journal 2003 372 1 173 181 (Pubitemid 36609619)
107. Boots A. W., Balk J. M., Bast A., Haenen G. R., The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin-induced toxicity Biochemical and Biophysical Research Communications 2005 338 923 929 (Pubitemid 41597730)
108. Boots A. W., Li H., Schins R. P. F., Duffin R., Heemskerk J. W. M., Bast A., Haenen G. R. M. M., The quercetin paradox Toxicology and Applied Pharmacology 2007 222 1 89 96 (Pubitemid 46962659)
109. Ferraresi R., Troiano L., Roat E., Lugli E., Nemes E., Nasi M., Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin Free Radical Research 2005 39 1249 1258 (Pubitemid 41601428)
110. Kim G. N., Jang H. D., Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells Annals of the New York Academy of Sciences 2009 1171 530 537
111. Cossarizza A., Troiano L., Ferraresi R., Roat E., Gibellini L., Bertoncelli L., Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry Nature Protocols 2009 4 1790 1797
112. Robaszkiewicz A., Balcerczyk A., Bartosz G., Antioxidative and prooxidative effects of quercetin on A549 cells Cell Biology International 2007 31 1245 1250 (Pubitemid 47030992)
113. Zhang Q., Zhao X. H., Wang Z. J., Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis Toxicology in Vitro 2009 23 797 807
114. Jeong J.-H., An J. Y., Kwon Y. T., Rhee J. G., Lee Y. J., Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression Journal of Cellular Biochemistry 2009 106 1 73 82
115. Yang J.-H., Hsia T.-C., Kuo H.-M., Chao P.-D. L., Chou C.-C., Wei Y.-H., Chung J.-G., Inhibition of lung cancer cell growth by quercetin glucuronides via G 2/M arrest and induction of apoptosis Drug Metabolism and Disposition 2006 34 2 296 304 (Pubitemid 43145031)
116. Nair H. K., Rao K. V., Aalinkeel R., Mahajan S., Chawda R., Schwartz S. A., Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes Clinical and Diagnostic Laboratory Immunology 2004 11 63 69 (Pubitemid 38090653)
117. Mu C., Jia P., Yan Z., Liu X., Li X., Liu H., Quercetin induces cell cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2) Methods and Findings in Experimental and Clinical Pharmacology 2007 29 179 183 (Pubitemid 46918296)
118. Bandele O. J., Clawson S. J., Osheroff N., Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement Chemical Research in Toxicology 2008 21 1253 1260 (Pubitemid 351967390)
119. Lopez-Lazaro M., Willmore E., Austin C. A., The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells Mutation Research 2010 696 41 47
120. Barjesteh Van Waalwijk Van Doorn-Khosrovani S., Janssen J., Maas L. M., Godschalk R. W., Nijhuis J. G., Van Schooten F. J., Dietary flavonoids induce MLL translocations in primary human CD34+ cells Carcinogenesis 2007 28 1703 1709 (Pubitemid 47289032)
121. Lugli E., Troiano L., Ferraresi R., Roat E., Prada N., Nasi M., Pinti M., Cooper E. L., Cossarizza A., Characterization of cells with different mitochondrial membrane potential during apoptosis Cytometry Part A 2005 68 1 28 35 (Pubitemid 41572060)
122. Mouria M., Gukovskaya A. S., Jung Y., Buechler P., Hines O. J., Reber H. A., Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis International Journal of Cancer 2002 98 761 769 (Pubitemid 34225629)
123. Lee T.-J., Kim O. H., Kim Y. H., Lim J. H., Kim S., Park J.-W., Kwon T. K., Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells Cancer Letters 2006 240 2 234 242 (Pubitemid 44109922)
124. Ma H., Nguyen C., Lee K. S., Kahn M., Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression Oncogene 2005 24 3619 3631 (Pubitemid 40756231)
125. Shan B. E., Wang M. X., Li R. Q., Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway Cancer Investigation 2009 27 604 612
126. Kuo P. C., Liu H. F., Chao J. I., Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells The Journal of Biological Chemistry 2004 279 55875 55885
127. Siegelin M. D., Reuss D. E., Habel A., Rami A., von Deimling A., Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells Neuro-Oncology 2009 11 122 131
128. Gupta K., Panda D., Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity Biochemistry 2002 41 13029 13038 (Pubitemid 35215787)
129. Jung Y. H., Heo J., Lee Y. J., Kwon T. K., Kim Y. H., Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5 Life Sciences 2010 86 351 357
130. Kim J. Y., Kim E. H., Park S. S., Lim J. H., Kwon T. K., Choi K. S., Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation Journal of Cellular Biochemistry 2008 105 1386 1398
131. Tanigawa S., Fujii M., Hou D.-X., Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells Bioscience, Biotechnology and Biochemistry 2008 72 3 797 804 (Pubitemid 351463685)
132. Lim J. H., Park J.-W., Min D. S., Chang J.-S., Lee Y. H., Park Y. B., Choi K. S., Kwon T. K., NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells Apoptosis 2007 12 2 411 421 (Pubitemid 46169920)
133. Polyak K., Xia Y., Zweier J. L., Kinzler K. W., Vogelstein B., A model for p53-induced apoptosis Nature 1997 389 6648 300 305 (Pubitemid 27406646)
134. Yoon K.-A., Nakamura Y., Arakawa H., Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses Journal of Human Genetics 2004 49 3 134 140 (Pubitemid 38506727)
135. Hussain S. P., Amstad P., He P., Robles A., Lupold S., Kaneko I., p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis Cancer Research 2004 64 2350 2356 (Pubitemid 38523887)
136. O'Connor J. C., Wallace D. M., O'Brien C. J., Cotter T. G., A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell Investigative Ophthalmology and Visual Science 2008 49 4237 4244
137. Budanov A. V., Shoshani T., Faerman A., Zelin E., Kamer I., Kalinski H., Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability Oncogene 2002 21 6017 6031
138. Velasco-Miguel S., Buckbinder L., Jean P., Gelbert L., Talbott R., Laidlaw J., PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes Oncogene 1999 18 127 137 (Pubitemid 29060586)
139. Sablina A. A., Budanov A. V., Ilyinskaya G. V., Agapova L. S., Kravchenko J. E., Chumakov P. M., The antioxidant function of the p53 tumor suppressor Nature Medicine 2005 11 12 1306 1313 (Pubitemid 41752911)
140. Ding B., Chi S. G., Kim S. H., Kang S., Cho J. H., Kim D. S., Role of p53
141. Agurs-Collins T., Rosenberg L., Makambi K., Palmer J. R., Adams-Campbell L., Dietary patterns and breast cancer risk in women participating in the Black Women's Health Study American Journal of Clinical Nutrition 2009 90 3 621 628
142. Matsuo M., Sasaki N., Saga K., Kaneko T., Cytotoxicity of flavonoids toward cultured normal human cells Biological and Pharmaceutical Bulletin 2005 28 253 259 (Pubitemid 40880004)
143. Caltagirone S., Rossi C., Poggi A., Ranelletti F. O., Natali P. G., Brunetti M., Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential International Journal of Cancer 2000 87 595 600 (Pubitemid 30639822)
144. Lee J. C., Kim J., Park J. K., Chung G. H., Jang Y. S., The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis Experimental Cell Research 2003 291 386 397 (Pubitemid 37485726)
145. Ansari M. A., Abdul H. M., Joshi G., Opii W. O., Butterfield D. A., Protective effect of quercetin in primary neurons against Abeta(142): relevance to Alzheimer's disease The Journal of Nutritional Biochemistry 2009 20 269 275
146. Sharma V., Mishra M., Ghosh S., Tewari R., Basu A., Seth P., Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection Brain Research Bulletin 2007 73 55 63 (Pubitemid 46710246)
147. Kamaraj S., Vinodhkumar R., Anandakumar P., Jagan S., Ramakrishnan G., Devaki T., The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyrene Biological and Pharmaceutical Bulletin 2007 30 2268 2273 (Pubitemid 350223724)
148. Volate S. R., Davenport D. M., Muga S. J., Wargovich M. J., Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin) Carcinogenesis 2005 26 1450 1456 (Pubitemid 41417889)
149. Devipriya S., Ganapathy V., Shyamaladevi C. S., Suppression of tumor growth and invasion in 9,10 dimethyl benz(a) anthracene induced mammary carcinoma by the plant bioflavonoid quercetin Chemico-Biological Interactions 2006 162 106 113 (Pubitemid 44189958)
150. Seufi A. M., Ibrahim S. S., Elmaghraby T. K., Hafez E. E., Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences Journal of Experimental and Clinical Cancer Research 2009 28 80
151. Castillo-Pichardo L., Martinez-Montemayor M. M., Martinez J. E., Wall K. M., Cubano L. A., Dharmawardhane S., Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols Clinical and Experimental Metastasis 2009 26 505 516
152. Ghosh A., Mandal A. K., Sarkar S., Panda S., Das N., Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats Life Sciences 2009 84 75 80
153. Vicentini F. T., Simi T. R., Del Ciampo J. O., Wolga N. O., Pitol D. L., Iyomasa M. M., Quercetin in w/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo European Journal of Pharmaceutics and Biopharmaceutics 2008 69 948 957
154. Kale R., Saraf M., Juvekar A., Tayade P., Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin-cyclodextrin binary system Journal of Pharmacy and Pharmacology 2006 58 1351 1358 (Pubitemid 44580565)
155. Yuan Z. P., Chen L. J., Fan L. Y., Tang M. H., Yang G. L., Yang H. S., Liposomal quercetin efficiently suppresses growth of solid tumors in murine models Clinical Cancer Research 2006 12 3193 3199
156. Mandal A. K., Das S., Mitra M., Chakrabarti R. N., Chatterjee M., Das N., Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model Journal of Experimental Therapeutics and Oncology 2008 7 123 133
157. Cruz-Correa M., Shoskes D. A., Sanchez P., Zhao R., Hylind L. M., Wexner S. D., Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis Clinical Gastroenterology and Hepatology 2006 4 1035 1038 (Pubitemid 44118839)
158. Harwood M., Danielewska-Nikiel B., Borzelleca J. F., Flamm G. W., Williams G. M., Lines T. C., A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties Food and Chemical Toxicology 2007 45 2179 2205 (Pubitemid 47451573)
159. Stavric B., Quercetin in our diet: from potent mutagen to probable anticarcinogen Clinical Biochemistry 1994 27 245 248 (Pubitemid 24300416)
160. Manach C., Morand C., Crespy V., Demigne C., Texier O., Regerat F., Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties FEBS Letters 1998 426 331 336 (Pubitemid 28218374)
161. Rastogi P. B., Levin R. E., Induction of sperm abnormalities in mice by quercetin Environmental Mutagen 1987 9 79 86 (Pubitemid 17008269)
162. Pamukcu A. M., Yalciner S., Hatcher J. F., Bryan G. T., Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum) Cancer Research 1980 40 3468 3472 (Pubitemid 10003733)
163. Hirono I., Ueno I., Hosaka S., Takanashi H., Matsushima T., Sugimura T., Carcinogenicity examination of quercetin and rutin in ACI rats Cancer Letters 1981 13 15 21 (Pubitemid 11071016)
164. Ito N., Hagiwara A., Tamano S., Kagawa M., Shibata M., Kurata Y., Lack of carcinogenicity of quercetin in F344/DuCrj rats Japanese Journal of Cancer Research 1989 80 317 325 (Pubitemid 20035983)
165. Hirono I., Ogino H., Fujimoto M., Yamada K., Yoshida Y., Ikagawa M., Induction of tumors in ACI rats given a diet containing ptaquiloside, a bracken carcinogen Journal of the National Cancer Institute 1987 79 1143 1149 (Pubitemid 17165287)
166. Mulholland P. J., Ferry D. R., Anderson D., Hussain S. A., Young A. M., Cook J. E., Hodgkin E., Seymour L. W., Kerr D. J., Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin Annals of Oncology 2001 12 2 245 248 (Pubitemid 32223876)